These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1909515)
1. Cross-resistance of human multidrug-resistant cells to mitomycin C. Yusa K; Sato W; Yamazaki A; Tsukahara S; Tsuruo T Anticancer Res; 1991; 11(3):1301-4. PubMed ID: 1909515 [TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873 [TBL] [Abstract][Full Text] [Related]
3. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells. Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080 [TBL] [Abstract][Full Text] [Related]
4. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells. Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793 [TBL] [Abstract][Full Text] [Related]
5. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Yusa K; Tsuruo T Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930 [TBL] [Abstract][Full Text] [Related]
6. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792 [TBL] [Abstract][Full Text] [Related]
7. FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line. Natazuka T Kobe J Med Sci; 1992 Dec; 38(6):347-63. PubMed ID: 1284834 [TBL] [Abstract][Full Text] [Related]
8. Acquired vs innate multidrug resistance and the effect of calcium channel blockers. Tsuruo T Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516 [TBL] [Abstract][Full Text] [Related]
9. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance]. Kimura I; Ohnoshi T; Hiraki S; Miyamoto H Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):830-6. PubMed ID: 3032107 [TBL] [Abstract][Full Text] [Related]
10. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement. Naito M; Tsuruo T Cancer Res; 1989 Mar; 49(6):1452-5. PubMed ID: 2924298 [TBL] [Abstract][Full Text] [Related]
11. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555 [TBL] [Abstract][Full Text] [Related]
14. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. Kavallaris M; Madafiglio J; Norris MD; Haber M Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660 [TBL] [Abstract][Full Text] [Related]
15. [Establishment of adriamycin-resistant human ovarian carcinoma cell line and its mechanism of multidrug resistance]. Li PY; Lin C Yao Xue Xue Bao; 1995; 30(4):258-62. PubMed ID: 7660793 [TBL] [Abstract][Full Text] [Related]
16. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide. Wei HL; Wu YJ; Jing T; Bai DC; Ma LF Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281 [TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416 [TBL] [Abstract][Full Text] [Related]
18. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines. Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930 [TBL] [Abstract][Full Text] [Related]
19. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Slovak ML; Hoeltge GA; Dalton WS; Trent JM Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]